Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:17   Issue: 7
Pp: 585-585
William Cho
DOI: 10.2174/156800961707170809143435

Influence of Aldo-keto Reductase 1C3 in Prostate Cancer - A Mini Review

Volume:17   Issue: 7
Pp: 603-616
Nishi Karunasinghe*, Jonathan Masters, Jack U. Flanagan and Lynnette R. Ferguson
DOI: 10.2174/1568009617666170330115722

Insight into Discovery of Next Generation Reversible TMLR Inhibitors Targeting EGFR Activating and Drug Resistant T790M Mutants

Volume:17   Issue: 7
Pp: 617-636
Subhash Mohan Agarwal*, Divyani Pal, Mansi Gupta and Ravi Saini
DOI: 10.2174/1568009617666170330112842

HR+, HER2– Advanced Breast Cancer and CDK4/6 Inhibitors: Mode of Action, Clinical Activity, and Safety Profiles open access plus

Volume:17   Issue: 7
Pp: 637-649
Sarah L. Sammons, Donna L. Topping and Kimberly L. Blackwell*
DOI: 10.2174/1568009617666170330120452

The Role of Mifamurtide in Chemotherapy-induced Osteoporosis of Children with Osteosarcoma

Volume:17   Issue: 7
Pp: 650-656
Giulia Bellini, Daniela Di Pinto, Chiara Tortora, Iolanda Manzo, Francesca Punzo, Fiorina Casale and Francesca Rossi*
DOI: 10.2174/1568009616666161215163426

Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An In Silico Approach

Volume:17   Issue: 7
Pp: 657-668
Farzaneh Mohamadi Farsani, Mohamad Reza Ganjalikhany and Sadeq Vallian*
DOI: 10.2174/1568009617666161109142629

Anti-Tumorigenic Effects of Resveratrol in Lung Cancer Cells Through Modulation of c-FLIP

Volume:17   Issue: 7
Pp: 669-680
Clayton Wright, Anand Krishnan V. Iyer, Juan S. Yakisich and Neelam Azad*
DOI: 10.2174/1568009617666170315162932